Thermo Fisher Scientific said on Tuesday that its next-generation sequencing-based Oncomine Dx Target Test has been approved by the US FDA as a companion diagnostic (CDx) to identify patients with advanced RET-driven lung and thyroid cancers who may be eligible for Lilly’s Retevmo (selpercatinib).

Two SARS-CoV-2 antigen tests from Watmind USA and Genabio Diagnostics have received Emergency Use Authorization from the US Food and Drug Administration for at-home use without a prescription.

PreventionGenetics said Thursday that it has been granted marketing authorization for its POMC/PCSK1/LEPR companion diagnostic as a Class II device by the US Food and Drug Administration.

On May 18, the treatment report of the first Chinese produced SARS-CoV-2 oral drug was announced.

The scientists, led by Joseph Vinetz, MD, an infectious diseases specialist, were interested to find out if an oral medication used to treat pancreatitis could reduce the viral load (the amount of virus in your body) of SARS-CoV-2 and improve symptoms in people newly diagnosed with COVID-19.

Overweight or obesity, an unfavorable distribution of fat in the body and the development of type 2 diabetes are often associated with a reduced effect of the hormone insulin in many organs, including the brain (insulin resistance).

On June 26, 2021, Shanghai, Sanyou Biopharmaceutical (Shanghai) Co., Ltd. announced the closing of series B financing. This financing round was co-led by LH Ventures and Montesy Investment and followed by Grand Mount Capital and Seeking Capital (an existing investor).

Keck Medicine of USC physicians are enrolling patients as part of an international clinical trial, designed to assess the safety and efficacy of the antiviral drug DAS181, as a possible treatment for patients with severe COVID-19.

China Food and Drug Administration (CFDA) recently released the 2014 Drug Review Annual Report. The Annual Report describes the general situation of drug registration acceptance, review and approval in 2014, and analyzes the data of accepta

Abbott Laboratories has developed a portable tool to help law enforcement agencies crack down on people driving under the influence. The Abbott Park, IL-based company looks to expand the reach of the diagnostic tool – SoToxa Mobile Test Sy